Literature DB >> 15473024

Cetuximab in colon cancer.

Andry F Costa, Guilherme B Sander, Paulo D Picon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15473024

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.

Authors:  Nipun B Merchant; Igor Voskresensky; Christopher M Rogers; Bonnie Lafleur; Peter J Dempsey; Ramona Graves-Deal; Frank Revetta; A Coe Foutch; Mace L Rothenberg; Mary K Washington; Robert J Coffey
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

2.  Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer.

Authors:  H Charles Manning; Nipun B Merchant; A Coe Foutch; John M Virostko; Shelby K Wyatt; Chirayu Shah; Eliot T McKinley; Jingping Xie; Nathan J Mutic; M Kay Washington; Bonnie LaFleur; Mohammed Noor Tantawy; Todd E Peterson; M Sib Ansari; Ronald M Baldwin; Mace L Rothenberg; Darryl J Bornhop; John C Gore; Robert J Coffey
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

3.  Dysregulation of adenosine kinase isoforms in breast cancer.

Authors:  Bahar Shamloo; Nandita Kumar; Randall H Owen; Jesica Reemmer; John Ost; R Serene Perkins; Hai-Ying Shen
Journal:  Oncotarget       Date:  2019-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.